378 related articles for article (PubMed ID: 30219071)
21. Clinical relevance of circulating cell-free microRNAs in ovarian cancer.
Nakamura K; Sawada K; Yoshimura A; Kinose Y; Nakatsuka E; Kimura T
Mol Cancer; 2016 Jun; 15(1):48. PubMed ID: 27343009
[TBL] [Abstract][Full Text] [Related]
22. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
[TBL] [Abstract][Full Text] [Related]
23. miR-106a represses the Rb tumor suppressor p130 to regulate cellular proliferation and differentiation in high-grade serous ovarian carcinoma.
Liu Z; Gersbach E; Zhang X; Xu X; Dong R; Lee P; Liu J; Kong B; Shao C; Wei JJ
Mol Cancer Res; 2013 Nov; 11(11):1314-25. PubMed ID: 24045973
[TBL] [Abstract][Full Text] [Related]
24. Potential biomarker of circulating hsa-miR-1273g-3p level for detection of recurrent epithelial ovarian cancer.
Günel T; Gumusoglu E; Dogan B; Ertem FB; Hosseini MK; Cevik N; Senol T; Topuz S; Aydinli K
Arch Gynecol Obstet; 2018 Dec; 298(6):1173-1180. PubMed ID: 30264202
[TBL] [Abstract][Full Text] [Related]
25. Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma.
Yue X; Lan F; Hu M; Pan Q; Wang Q; Wang J
J Neurosurg; 2016 Jan; 124(1):122-8. PubMed ID: 26230475
[TBL] [Abstract][Full Text] [Related]
26. Serum microRNA-145 as a novel biomarker in human ovarian cancer.
Liang H; Jiang Z; Xie G; Lu Y
Tumour Biol; 2015 Jul; 36(7):5305-13. PubMed ID: 25722112
[TBL] [Abstract][Full Text] [Related]
27. Combining serum microRNA and CA-125 as prognostic indicators of preoperative surgical outcome in women with high-grade serous ovarian cancer.
Shah JS; Gard GB; Yang J; Maidens J; Valmadre S; Soon PS; Marsh DJ
Gynecol Oncol; 2018 Jan; 148(1):181-188. PubMed ID: 29132874
[TBL] [Abstract][Full Text] [Related]
28. Exosomal miR-1246 in serum as a potential biomarker for early diagnosis of gastric cancer.
Shi Y; Wang Z; Zhu X; Chen L; Ma Y; Wang J; Yang X; Liu Z
Int J Clin Oncol; 2020 Jan; 25(1):89-99. PubMed ID: 31506750
[TBL] [Abstract][Full Text] [Related]
29. Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer.
Liu Q; Yu Z; Yuan S; Xie W; Li C; Hu Z; Xiang Y; Wu N; Wu L; Bai L; Li Y
Oncotarget; 2017 Feb; 8(8):13048-13058. PubMed ID: 28055956
[TBL] [Abstract][Full Text] [Related]
30. Extracellular microRNA profiling for prognostic prediction in patients with high-grade serous ovarian carcinoma.
Yoshida K; Yokoi A; Matsuzaki J; Kato T; Ochiya T; Kajiyama H; Yamamoto Y
Cancer Sci; 2021 Dec; 112(12):4977-4986. PubMed ID: 34618992
[TBL] [Abstract][Full Text] [Related]
31. The Value of Plasma-Based MicroRNAs as Diagnostic Biomarkers for Ovarian Cancer.
Wang W; Yin Y; Shan X; Zhou X; Liu P; Cao Q; Zhu D; Zhang J; Zhu W
Am J Med Sci; 2019 Oct; 358(4):256-267. PubMed ID: 31353030
[TBL] [Abstract][Full Text] [Related]
32. Exosomal miRNA Signatures for Late-Onset Acute Graft-Versus-Host Disease in Allogenic Hematopoietic Stem Cell Transplantation.
Yoshizawa S; Umezu T; Saitoh Y; Gotoh M; Akahane D; Kobayashi C; Ohyashiki JH; Ohyashiki K
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30142940
[TBL] [Abstract][Full Text] [Related]
33. Expression of serum miR-218 in hepatocellular carcinoma and its prognostic significance.
Yang L; Xu Q; Xie H; Gu G; Jiang J
Clin Transl Oncol; 2016 Aug; 18(8):841-7. PubMed ID: 26586116
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer.
Taylor DD; Gercel-Taylor C
Gynecol Oncol; 2008 Jul; 110(1):13-21. PubMed ID: 18589210
[TBL] [Abstract][Full Text] [Related]
35. Circular RNA profiling reveals circRNA1656 as a novel biomarker in high grade serous ovarian cancer.
Gao Y; Zhang C; Liu Y; Wang M
Biosci Trends; 2019 May; 13(2):204-211. PubMed ID: 31019161
[TBL] [Abstract][Full Text] [Related]
36. Serum miRNAs panel (miR-16-2*, miR-195, miR-2861, miR-497) as novel non-invasive biomarkers for detection of cervical cancer.
Zhang Y; Zhang D; Wang F; Xu D; Guo Y; Cui W
Sci Rep; 2015 Dec; 5():17942. PubMed ID: 26656154
[TBL] [Abstract][Full Text] [Related]
37. Study of microRNAs-21/221 as potential breast cancer biomarkers in Egyptian women.
Motawi TM; Sadik NA; Shaker OG; El Masry MR; Mohareb F
Gene; 2016 Sep; 590(2):210-9. PubMed ID: 26827795
[TBL] [Abstract][Full Text] [Related]
38. Predictive Relevance of Circulating miR-622 in Patients with Newly Diagnosed and Recurrent High-Grade Serous Ovarian Carcinoma.
Vigneron N; Vernon M; Meryet-Figuière M; Lambert B; Briand M; Louis MH; Krieger S; Joly F; Lheureux S; Blanc-Fournier C; Gauduchon P; Poulain L; Denoyelle C
Clin Chem; 2020 Feb; 66(2):352-362. PubMed ID: 32040573
[TBL] [Abstract][Full Text] [Related]
39. MiR-585-3p suppresses tumor proliferation and migration by directly targeting CAPN9 in high grade serous ovarian cancer.
Lu X; Li G; Liu S; Wang H; Chen B
J Ovarian Res; 2021 Jul; 14(1):90. PubMed ID: 34238324
[TBL] [Abstract][Full Text] [Related]
40. microRNA-150: a promising novel biomarker for hepatitis B virus-related hepatocellular carcinoma.
Yu F; Lu Z; Chen B; Dong P; Zheng J
Diagn Pathol; 2015 Jul; 10():129. PubMed ID: 26215970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
